Use cases
We help you create your AI algorithm based either on your data or new images acquired with our devices. Full solutions can be deployed in our easy-to-use web and smartphones (edge-AI) or you can deploy the AI models in your own infrastructure. Full solutions can be deployed in our easy-to-use web and smartphones (edge-AI) or you can deploy the AI models in your own infrastructure.
Differential cell count in bone marrow aspirates
Hematology
Learn more
Detection and quantification of geohelminths
Neglected Tropical Diseases
Learn more
Detection and quantification of filariae
Parasitology
Learn more
Quality control for visceral leishmaniasis
Neglected tropical diseases
Implementation of digital microscopy quality control for the diagnosis of visceral leishmaniasis. Development of an AI model for rapid and accurate diagnosis of visceral leishmaniasis. In collaboration with DNDi, FIND, Kenya Medical Research Institute (Kenya), University of Gondar (Ethiopia) and Instituto de Salud Carlos III (Spain).
Learn more
Cerebrospinal fluid cell counts
Infectious diseases
AI model for cell counting and differentiation in cerebrospinal fluid samples from patients with suspected meningitis, in collaboration with the Rabat Children’s Hospital (Morocco), Manhiça Health Research Centre (Mozambique), ISGlobal and Newborn Solutions.
Detection of Onchocerca volvulus
Infectious diseases
Scanning of subcutaneous nodule samples for detecting Onchocerca volvulus. In collaboration with the Korle-Bu Teaching Hospital (Ghana).
Blood parasite detection
Infectious diseases
AI model for the detection and quantification of parasites in blood samples, whether for malaria, Chagas disease, leishmaniasis or filariasis. In collaboration with the Universidad Mayor de San Simón (Bolivia), Oswaldo Cruz Foundation – Fiocruz (Brazil), Institute for Medical Research IMR (Malaysia), Fundación Mundo Sano (Argentina) and Instituto de Salud Carlos III (Spain).
Learn more
Quantification and subtyping of lung lesions
COVID-19
Identification, quantification and characterisation of different COVID-19 lesion patterns in CT images. In collaboration with Hospital Clínic de Barcelona, Clínica Universidad de Navarra, Hospital La Paz and Fundación Jiménez Díaz (Spain).
Learn more
Quantification of schistosomiasis
Infectious diseases
AI model for automatic quantification of parasite eggs in stool or urine samples. In collaboration with the University of Berkeley and the Bill & Melinda Gates Foundation.
Learn more
Bone marrow digitalization
Hematology
Innovation program for the digitization and analysis of bone marrow samples in the haematology services of more than 10 Spanish hospitals. In collaboration with GSK, Hospital Nuestra Señora de la Candelaria, Hospital Parc Taulí, Hospital Vall d’Hebron, Hospital Miguel Servet, Hospital Peset, etc.
RetiSpot: fundus digitalization
Patology
Portable, 3D-printed, smartphone-controlled retinograph connected to a telemedicine web platform for the screening of fundus lesions. In collaboration with the Institut Català de Retina, ISGlobal, Centro de Investigación en Saúde de Manhiça (CISM), (Mozambique) and the UPM.
RDT universal reader
Several diseases
An algorithm capable of interpreting the result of any rapid test up to 3 bands. This model has been tested for several pathologies including: COVID-19, Chagas disease and Cryptococcosis. In collaboration with the Hospital Ramón y Cajal (Spain).
Learn more
Automatic reading of COVID-19 rapid tests
COVID-19
AI model for reading COVID-19 antigen and antibody tests. In collaboration with the Hospital Ramón y Cajal (Spain).
Learn more
Quantification of Cryptococcus
Micology
Algorithm capable of quantifying the intensity of LFA bands for both the reading of semi-quantitative cryptococcosis tests and their correlation with antigen concentration in qualitative tests. In collaboration with GAFFI (Switzerland), Asociación de Salud Integral (Guatemala) and Instituto de Salud Carlos III (Spain).
Learn more
Digitization and quality control of rapid Chagas disease tests
Infectious diseases
Evaluation and comparison of the effectiveness of several LFA for Chagas disease in endemic countries, with the aim of determining the most accurate and reliable LFA in these regions, and storing its results for quality control purposes. In collaboration with FIND (Argentina, Colombia and Bolivia).